Rxsight Inc Stock Ownership - Who owns Rxsight?

Insider buying vs selling

Have Rxsight Inc insiders been buying or selling?
Bakker Juliet TammenomsDirector2023-09-112,950$30.01
Bakker Juliet TammenomsDirector2023-09-0810,033$30.25
Bakker Juliet TammenomsDirector2023-09-0719,967$30.10
Shweta ManiarDirector2023-08-294,292$28.06
Bakker Juliet TammenomsDirector2023-08-2516,208$29.25
Bakker Juliet TammenomsDirector2023-08-1814,651$29.07
Bakker Juliet TammenomsDirector2023-08-1718,484$30.06
Ilya GoldshlegerChief Operating Officer2023-07-2625,475$3.93
Bakker Juliet TammenomsDirector2023-02-10480,000$12.50
Ronald M. Md KurtzPresident CEO2023-02-1040,000$12.50

1 of 1

RXST insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RXST insiders and whales buy or sell their stock.

RXST Shareholders

What type of owners hold Rxsight Inc stock?
Ra Capital Management LP8.56%3,052,796$83.01MInstitution
Ra Capital Management LP8.56%3,052,796$83.01MInsider
Artisan Partners Limited Partnership5.83%2,078,470$56.51MInstitution
Rxsight I LLC5.66%2,016,778$54.84MInsider
Richard M. Wolfen5.16%1,840,244$50.04MInsider
Ronald M. Md Kurtz4.98%1,774,220$48.24MInsider
Blackrock Inc4.57%1,629,928$44.32MInstitution
Morgan Stanley4.23%1,507,075$40.98MInstitution
Lord Abbett Co LLC4.02%1,431,221$38.91MInstitution
Bruce C. Robertson3.89%1,385,037$37.66MInsider

1 of 3

RXST vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RXST61.53%36.15%Net BuyingNet Selling
QTRX64.42%35.58%Net BuyingNet Buying
AVNS93.75%2.39%Net SellingNet Selling
CTKB56.49%23.62%Net SellingNet Selling
SIBN55.92%44.08%Net SellingNet Selling

Rxsight Stock Ownership FAQ

Who owns Rxsight?

Rxsight (NASDAQ: RXST) is owned by 61.53% institutional shareholders, 36.15% Rxsight insiders, and 2.32% retail investors. Ra Capital Management LP is the largest individual Rxsight shareholder, owning 3.05M shares representing 8.56% of the company. Ra Capital Management LP's Rxsight shares are currently valued at $82.58M.

If you're new to stock investing, here's how to buy Rxsight stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.